On April 29, the top nine biotech rose 5.58%, and the Rongtong health industry flexibly allocated a mixed A/B fund to hold a heavy position in the stock_Stock News_Market Gold Online

Post date April 29, 2022 — 17:20 Post Lock

Key Data Concepts:
? These are the company names, stock quotes, topics, and entities related to this data.

Full Data

?
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on the Chinese Stock Markets

Need this critical market data?

Access thousands of market events, data points, and news articles!

Already have an account?
Login

Related Data

Jiuqiang Bio: The fully automatic immunohistochemical analyzer and supporting antibody reagents produced by our company have strong international competitiveness and high technical threshold

May 17, 2022 — 07:07

Jiuqiang Bio: The immune reagents produced by our company are only suitable for clinical diagnosis

May 17, 2022 — 07:07

Jiuqiang Bio: The company's novel coronavirus (2019-nCOV) antigen detection kit (latex method) product has obtained EU CE access qualification

May 17, 2022 — 07:06

Central Bureau Observation of Nucleic Acid Testing①｜The demand for new crown testing has changed from strong to weak, and the changes in the IVD industry and the new situation 21 Economic Net

May 12, 2022 — 13:32

The first five-year plan for bio-economy was issued, and concept stocks pulled up the daily limit at the end of the session. Please collect the list of the latest performance growth! Multiple consecutive daily limit, this sector started a rebound mode

May 11, 2022 — 09:48

Jiuqiang Bio: As of April 30, 2022, the cumulative repurchase of about 850,000 shares accounted for 0.1436% _ Oriental Fortune Net

May 5, 2022 — 18:41

Jiuqiang Bio (300406): Verification Opinion of Huachuang Securities Co., Ltd. on the realization of the 2021 annual performance commitment of Beijing Jiuqiang Biotechnology Co., Ltd.'s major asset purchase and related-party transactions- CFi.CN Zhongcai.com

April 28, 2022 — 23:01

There have been changes in the executives of many pharmaceutical companies such as Asia Pacific Pharmaceuticals and Jiuqiang Bio

April 20, 2022 — 11:41

New coronavirus antigen testing company has outstanding performance

April 20, 2022 — 05:39

Home » News » On April 29, the top nine biotech rose 5.58%, and the Rongtong health industry flexibly allocated a mixed A/B fund to hold a heavy position in the stock_Stock News_Market Gold Online